What Antellis does

Antellis is an independent French analytical laboratory founded in 2003 and headquartered in Toulouse, operating from a 390 m² facility under telesurveillance. The company specializes in elemental and pharmaceutical analysis, research, and dosing solutions using inductively coupled plasma mass spectrometry (ICP-MS) as its core technology, complemented by inductively coupled plasma optical emission spectrometry (ICP-OES), high-pressure microwave digestion systems, and controlled-temperature sample storage. Its five service lines — pharmaceutical analysis, cosmetics testing, dietary supplements analysis, bioanalysis, and chemistry analysis — are built around regulatory frameworks including ICH Q3D, USP <232>/<233>, Ph. Eur. 5.20, and OECD GLP/GMP, with method validation delivered to ICH Q2(R1) standards. The laboratory is equipped with three ICP-MS instruments and one ICP-OES and has completed more than 100 bioanalytical studies covering toxicokinetics, pharmacokinetics, ADME, biodistribution, and transcutaneous passage.

The company serves B2B customers across pharmaceutical manufacturers, CMOs/CDMOs, API and excipient producers, cosmetic and nutraceutical manufacturers, and chemical and agro-food firms, primarily in Europe with sample-shipping-based international reach. Its commercial model is project-based professional services, with pricing determined per analysis or study and revenue driven by direct technical engagement with regulatory affairs and quality control functions at client companies. It was successfully inspected by the US FDA under cGMP in May 2013 and held French CIR (Crédit Impôt Recherche) accreditation in 2018, 2019, and 2020, validating its research and innovation profile.

Antellis remains privately held and founder-owned, with no disclosed external investment, no partnerships, no acquisitions, and no current open positions listed on its job page. Its go-to-market is anchored on regulatory expertise and technical credibility in elemental impurity compliance rather than on software, AI, or digital platform capabilities.

Name

Antellis

Legal name

Antellis

Website

https://antellis.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Antellis is an independent French analytical laboratory founded in 2003 in Toulouse, specializing in elemental impurity analysis by ICP-MS and ICP-OES for pharmaceutical, cosmetic, nutraceutical, chemical, and agro-food manufacturers requiring ICH Q3D, USP, and Ph. Eur. regulatory compliance testing.

Ownership category

akta.pro rank

Product category

Analytical Laboratory Services

NAICS

Testing Laboratories and Services (541380), Testing Laboratories and Services (54138)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Elemental Impurities & Trace Metals (ICP-MS) (HLAGADAJ)

akta.pro secondary industries

Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring) (AFALAAAE), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

Keywords

• Elemental impurity analysis
• ICP-MS testing services
• Pharmaceutical analytical laboratory
• ICH Q3D compliance testing
• Bioanalytical method validation

Headquarters

HQ city

Toulouse

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Analytical Testing Services: Antellis generates revenue through providing specialized elemental impurity analysis services to pharmaceutical, cosmetic, chemical, and agro-food industries. Services include screening, method validation, verification, and quantitative analysis for regulatory compliance (ICH Q3D, USP <232>, Ph. Eur. 5.20). Revenue is project-based, typically charged per analysis or study.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Antellis is an independent analytical laboratory founded in 2003 that performs elemental analysis using ICP-MS and ICP-OES instrumentation. The laboratory offers elemental impurity testing, semiquantitative screening of 50 elements, method development and validation, and bioanalytical studies for pharmaceutical, cosmetic, chemical, and agro-food industry clients to support regulatory compliance with ICH Q3D, USP <232>/<233>, and Ph. Eur. 5.20 requirements.

Product overview

Antellis is an independent analytical laboratory founded in 2003, specializing in elemental analysis by ICP-MS (Inductively Coupled Plasma Mass Spectrometry) and ICP-OES. The company offers a portfolio of five distinct service lines: Pharmaceutical Analysis Services, Cosmetics Testing Services, Dietary Supplements Analysis Services, Bioanalysis Services, and Chemistry Analysis Services. These services focus on quantifying elemental impurities, heavy metals, catalysts, and trace elements across pharmaceutical, cosmetic, chemical, and agro-food industry matrices. The company operates 390 m² of laboratory facilities equipped with 3 ICP-MS instruments and 1 ICP-OES, providing analytical services from screening to quality control, with method development and validation capabilities per ICH, USP, and Ph. Eur. guidelines.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Analysis Services Elemental impurity analysis of active pharmaceutical ingredients (APIs), excipients, raw materials, and drug products, including screening of 24 elemental impurities per ICH Q3D, semiquantitative screening of 50 elements, method verification, and method development/validation per ICH Q2(R1), Ph. Eur. and USP guidelines. Serves pharmaceutical laboratories, CMOs/CDMOs, API manufacturers, and excipient manufacturers for quality control, stability studies, and ICH Q3D risk analysis.
• Cosmetics Testing Services Heavy metal determination and elemental analysis for the cosmetic industry, including semiquantitative screening of 50 elements, quantification of mineral sun filters (TiO2, ZnO), heavy metals, and rare earth elements in raw materials, pigments, and finished cosmetic products. Targeted at cosmetic manufacturers facing new heavy-metal regulatory requirements.
• Dietary Supplements Analysis Services Elemental impurity and oligoelement quantitation for dietary supplements and nutraceuticals, covering heavy metals (As, Cd, Pb, Hg) at low regulatory thresholds and trace elements (I, Se, Cu, Ca, Mg, etc.) in matrices including yeast, plant extracts, algae, and spirulina.
• Bioanalysis Services ICP-MS method development and validation for quantifying elements in biological matrices (blood, plasma, urine, tissues) to support toxicokinetic, pharmacokinetic, ADME, biodistribution, and transcutaneous passage studies for metal-based drugs, metallic nanoparticles, and medical devices. Over 100 bioanalytical studies completed.
• Chemistry Analysis Services Heavy metal concentration determination in organic or mineral raw materials, solvents, polymers, and finished/semi-finished chemical products. Includes semiquantitative screenings, mineral impurity characterization, catalyst trace analysis, corrosion characterization, and production incident investigation (impurities, particle presence).

Quantifiable outcome

• Successfully completed over 100 bioanalytical studies including toxicokinetic, pharmacokinetic, ADME, biodistribution, and transcutaneous passage studies
• +1 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Intertek: Intertek provides pharmaceutical, cosmetic, and chemical testing services globally, including elemental impurity and heavy-metal analyses. It is a broad incumbent comparable to Antellis in service category though operating at significantly larger scale and geographic reach.
• ALS Limited: ALS is a global testing services group with strong life-sciences and pharmaceutical analytical capabilities. Its elemental and trace-metal testing labs serve pharmaceutical, environmental, and food customers in overlapping segments to Antellis, though across a much larger footprint.
• Eurofins Scientific: Eurofins is a global leader in bioanalytical, pharmaceutical, and food testing services with thousands of laboratories worldwide. It is a broad incumbent offering elemental impurity testing as part of its pharma services portfolio, competing for the same pharmaceutical compliance work as Antellis but at significantly larger scale.
• Charles River Laboratories: Charles River is a major CRO providing safety assessment, bioanalytical, and pharmaceutical testing services globally. Its bioanalytical and drug-development offerings overlap with Antellis' ADME/PK and metal-based drug bioanalysis services, though it operates at much greater scale and broader scope.
• SGS: SGS is a global testing, inspection, and certification company with extensive pharmaceutical and life-sciences laboratory services. It offers elemental and impurity testing within a much broader service portfolio, serving overlapping pharmaceutical, cosmetic, and chemical customers as Antellis.
• Synlab Group: Synlab operates a large European clinical and analytical laboratory network with pharma and chemical testing services. It competes in adjacent European testing markets with overlapping pharmaceutical and chemical analytical offerings to Antellis, with broader scope and scale.

Direct peers

• PharmaLex (now part of Cencora): PharmaLex provides regulatory affairs, quality, and CMC consulting including guidance on ICH Q3D and elemental impurity strategies for pharma clients. It is a direct peer in the elemental impurity regulatory-compliance workflow, often paired with or adjacent to analytical laboratory services like Antellis.
• NUVISAN Pharma Services: NUVISAN is a European CRO offering pharmaceutical analytics, bioanalysis, and impurity testing from its German facilities. It directly overlaps with Antellis in pharmaceutical impurity analysis, ICH Q3D compliance testing, and bioanalytical method development for small-molecule and biologic drugs.
• ABL Group: ABL Group is a European contract bioanalytical laboratory specializing in immunoassay, LC-MS/MS, and ICP-MS bioanalysis for vaccines, gene therapies, and biologics. It is a direct peer to Antellis in ICP-MS bioanalytical services for pharma/biotech, serving a similar customer base for regulated quantification studies.

Regional players

• BIOTRIAL: BIOTRIAL is a France-based CRO providing preclinical and clinical pharmacology services including bioanalytical method development. It is a regional peer with overlapping pharmaceutical bioanalytical capabilities and shares the French/European client base with Antellis.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/antellis2015
• LinkedInlinkedin.com/company/antellis

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antellis